Literature DB >> 8011405

Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation.

A Mortara1, M T La Rovere, M G Signorini, P Pantaleo, G Pinna, L Martinelli, C Ceconi, S Cerutti, L Tavazzi.   

Abstract

BACKGROUND AND OBJECTIVES: Autonomic dysfunction seems to be involved in the progression and prognosis of severe congestive heart failure. Parasympathetic activity can still be abnormal 4-8 weeks after haemodynamic improvement by heart transplantation. To identify patients in heart failure with a more pronounced neural derangement and to analyse the changes in sympathetic and parasympathetic activity soon after heart transplantation, spectral indices of heart rate variability were assessed in 30 patients in severe heart failure and in 13 patients after heart transplantation; a group of 15 age-matched subjects served as controls. METHODS AND
RESULTS: Heart rate variability was assessed by standard electrocardiography (ECG) in patients in heart failure and by oesophageal ECG in patients after heart transplantation. Compared with controls, the mean RR interval and total power were reduced in heart failure. The 30 patients showed two different patterns of heart rate variability: in 14 no power was detected in the low frequency band (0.03-0.15 Hz) (LF) and total power was mainly concentrated in the high frequency band (0.15-0.45 Hz) (HF), whereas in the remaining 16 patients power in the LF band was increased and power in HF band was reduced compared with the controls. Patients with undetectable LF had a lower mean RR interval and total power (745(25) v 864(36) ms, p < 0.05; 118(16) v 902(202) ms2, p < 0.001), higher concentration of plasma noradrenaline (635(75) v 329(54) pg/ml, p < 0.05), and worse clinical status and prognosis (4 deaths v no deaths at 6 month follow up) than patients with a dominant LF band. In the post-transplant patients both the mean PP interval of the remnant atrium and total power resembled results in the patients with heart failure; in 7 of the 13 post-transplant patients no power was detectable in the LF band: when both HF and LF power were present the results resembled those in the 16 patients in heart failure.
CONCLUSIONS: These data suggest that in more advanced stages of congestive heart failure, power spectral analysis of heart rate variability allows identification of a subgroup of patients with higher sympathetic activation and poorer clinical status who are at major risk of adverse events. In the short term after cardiac transplantation the spectral profile of the rhythm variability of the remnant atrium was not improved, suggesting that parasympathetic withdrawal and sympathetic hyperactivity persist, despite the restoration of ventricular function.

Entities:  

Mesh:

Year:  1994        PMID: 8011405      PMCID: PMC483717          DOI: 10.1136/hrt.71.5.422

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  41 in total

Review 1.  Beat to beat variability in cardiovascular variables: noise or music?

Authors:  M L Appel; R D Berger; J P Saul; J M Smith; R J Cohen
Journal:  J Am Coll Cardiol       Date:  1989-11-01       Impact factor: 24.094

2.  Decreased spontaneous heart rate variability in congestive heart failure.

Authors:  G Casolo; E Balli; T Taddei; J Amuhasi; C Gori
Journal:  Am J Cardiol       Date:  1989-11-15       Impact factor: 2.778

3.  Heart rate after coronary artery bypass grafting.

Authors:  K E Airaksinen; M J Ikäheimo; J T Takkunen
Journal:  Am J Cardiol       Date:  1987-12-01       Impact factor: 2.778

4.  Observations on the behavior of recipient atria after cardiac transplantation in man.

Authors:  E B Stinson; J S Schroeder; R B Griepp; N E Shumway; E Dong
Journal:  Am J Cardiol       Date:  1972-11-08       Impact factor: 2.778

5.  Responses of the sino-atrial node to change in pressure in the sinus node artery.

Authors:  K Hashimoto; S Tanaka; M Hirata; S Chiba
Journal:  Circ Res       Date:  1967-09       Impact factor: 17.367

6.  Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control.

Authors:  S Akselrod; D Gordon; F A Ubel; D C Shannon; A C Berger; R J Cohen
Journal:  Science       Date:  1981-07-10       Impact factor: 47.728

7.  Hemodynamic regulation: investigation by spectral analysis.

Authors:  S Akselrod; D Gordon; J B Madwed; N C Snidman; D C Shannon; R J Cohen
Journal:  Am J Physiol       Date:  1985-10

8.  Neurohumoral and hemodynamic effects of lower body negative pressure in patients with congestive heart failure.

Authors:  P K Mohanty; J A Arrowood; K A Ellenbogen; M D Thames
Journal:  Am Heart J       Date:  1989-07       Impact factor: 4.749

9.  Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.

Authors:  W N Leimbach; B G Wallin; R G Victor; P E Aylward; G Sundlöf; A L Mark
Journal:  Circulation       Date:  1986-05       Impact factor: 29.690

10.  Respiratory sinus arrhythmia in the denervated human heart.

Authors:  L Bernardi; F Keller; M Sanders; P S Reddy; B Griffith; F Meno; M R Pinsky
Journal:  J Appl Physiol (1985)       Date:  1989-10
View more
  12 in total

1.  Diastolic ventricular interaction in chronic heart failure: relation to heart rate variability and neurohumoral status.

Authors:  J J Atherton; D J Blackman; T D Moore; A W Bachmann; T J Tunny; H L Thomson; R D Gordon; M P Frenneaux
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

2.  Application of time series spectral analysis theory: analysis of cardiovascular variability signals.

Authors:  G D Pinna; R Maestri; A Di Cesare
Journal:  Med Biol Eng Comput       Date:  1996-03       Impact factor: 2.602

3.  Prognostic value of heart rate variability in time domain analysis in congestive heart failure.

Authors:  S Boveda; M Galinier; A Pathak; J Fourcade; B Dongay; D Benchendikh; P Massabuau; J M Fauvel; J M Senard; J P Bounhoure
Journal:  J Interv Card Electrophysiol       Date:  2001-06       Impact factor: 1.900

Review 4.  New potential uses for transdermal scopolamine (hyoscine).

Authors:  M T La Rovere; G M De Ferrari
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

5.  Power spectral analysis of heart rate variability and autonomic nervous system activity measured directly in healthy dogs and dogs with tachycardia-induced heart failure.

Authors:  Gianfranco Piccirillo; Masahiro Ogawa; Juan Song; Voon J Chong; Boyoung Joung; Seongwook Han; Damiano Magrì; Lan S Chen; Shien-Fong Lin; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2009-01-16       Impact factor: 6.343

6.  Dietary sodium effects on heart rate variability in salt sensitivity of blood pressure.

Authors:  Jessica D McNeely; B Gwen Windham; David E Anderson
Journal:  Psychophysiology       Date:  2007-11-28       Impact factor: 4.016

Review 7.  Silicon central pattern generators for cardiac diseases.

Authors:  Alain Nogaret; Erin L O'Callaghan; Renata M Lataro; Helio C Salgado; C Daniel Meliza; Edward Duncan; Henry D I Abarbanel; Julian F R Paton
Journal:  J Physiol       Date:  2015-01-05       Impact factor: 5.182

8.  Heart rate variability and non-linear dynamics in risk stratification.

Authors:  Juha S Perkiömäki
Journal:  Front Physiol       Date:  2011-11-09       Impact factor: 4.566

9.  Autonomic cardiac regulation during spontaneous nocturnal hypoglycemia in patients with type 1 diabetes.

Authors:  Minna L Koivikko; Mikko P Tulppo; Antti M Kiviniemi; Mika A Kallio; Juha S Perkiömäki; Pasi I Salmela; K E Juhani Airaksinen; Heikki V Huikuri
Journal:  Diabetes Care       Date:  2012-05-18       Impact factor: 19.112

10.  Prognostic Value of the Change in Heart Rate From the Supine to the Upright Position in Patients With Chronic Heart Failure.

Authors:  Micha T Maeder; Marzena Zurek; Hans Rickli; Daniel Tobler; Stephanie Kiencke; Thomas Suter; Se-Il Yoon; Barbara Julius; Matthias E Pfisterer; Hans-Peter Brunner-La Rocca
Journal:  J Am Heart Assoc       Date:  2016-08-08       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.